A patient-inspired project to develop communication aids to improve decision making between JIA families and health workers throughout their diagnosis and treatment journey.
The problem:
Background
Every project we take on at AiArthritis is the result of communicating with our community (our peers, as we are led by people affected by these diseases) and finding missing gaps in current education, advocacy/policy, or research that, if improved, would impact lives. In this case, while attending the annual American College of Rheumatology (ACR) and European Alliance of Associations for Rheumatology (EULAR) through our "Go With Us!" to Conferences program, we first noticed an increase in research around enthesitis - the inflammation of tendons and ligaments that attach to the bone. As many of us are 'spondy's' (persons living with one of the spondyloarthritis diseases) we began questioning how, if at all, this important disease feature is discussed in our rheumatology office visits. This, in conjunction with our efforts to improve patient-doctor communication, led to preliminary research with JIA families, focusing strongly on those affected by Enthesitis-Related Arthritis (ERA)/Juvenile Spondyloarthritis and Juvenile Psoriatic Arthritis (jPsA). As a result of this work, we identified several areas in the patient/family journey that, if addressed, could improve outcomes. And that's how this project came to be! Read more about the background and preliminary research.
About the Project
(1) Specialists identified in the journey include primary care physicans/general practitioners, physical therapists, orthopedic doctors, nurses
(2) Diagnoses Subtypes of JIA: Oligoarthritis, Polyarthritis, Systemic/Still's Disease, Psoriatic Arthritis, Enthesitis-Related Arthritis (may develop into juvenile Spondyloarthritis), Undifferentiated
By identifying communication gaps that exist along the diagnostic and therapeutic journey (focus on all health experts in that journey), we will be able to design new tools to bridge discussions between patients/families and their extended health team. In turn, we can improve diagnosis, therapy management, and healthcare outcomes.
Our work will include understanding communication issues associated with JIA as an umbrella condition and how needs vary among subgroups - with a focus on those subgroups that include enthesitis (ERA/jSpA, jPsA).
Enthesitis is not the same as joint pain. It is prominent in juvenile arthritis subgroups of jPsA, ERA (which may develop into juvenile Spondyloarthritis/jSpA).
Pull up a seat "at the table."
AiArthritis Voices 360 is an award-winning arthritis-based podcast created by our team to discuss relevant topics and concerns relating to the autoimmune and autoinflammatory diseases affecting our community. Each month we invite specialists, medical professionals, and members of our AiArthritis community to discuss a variety of topics and concerns - including Juvenile Idiopathic Arthritis! Check out the link below for more information on our talkshow episode dedicated to Juvenile Idiopathic Arthritis, including links to resources and an educational takeaway.
Have you or your family been affected by juvenile arthritis? On this episode, Tiffany is joined by Rochelle Lentini, CEO and President of Purple Playas Foundation, who have united with other specialists and families to identify additional tips to improve communication.
During this program, Rochelle and Tiffany discuss a new collaborative Juvenile Idiopathic Arthritis (JIA) project between AiArthritis and Purple Playas Foundation, along with Rheumatology Nurses Society and Novartis, to create discussion aids and question guidance to help families improve communication with all the professionals they meet along the way.
International Foundation for AiArthritis
6605 Nottingham Ave.
St. Louis, MO 63109-2661
Tax ID: 27-1214308
Copyright 2024. All rights reserved. Information on this site is intended for informational purposes only Our foundation does not engage in the practice of medicine. Please consult a physician to obtain personal healthcare and treatment options. 501(c) 3 Nonprofit Tax ID: 27-1214308.